Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
Public ClinicalTrials.gov record NCT00267358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Anorexia and cachexia are devastating complications in late-stage cancer patients and is strongly associated with mortality in these patients. Activation of Ghrelin receptors have been demonstrated to stimulate appetite. RC-1291 HCl, by virtue of its ghrelin like activity and Growth Hormone releasing effects may have a dual role in the reversal of cancer induced anorexia and cachexia. This placebo controlled study will evaluate the safety and efficacy of RC-1291 HCl in cancer patients with anorexia and cachexia.
Study identification
- NCT ID
- NCT00267358
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2005 (Type not available)
- Primary completion
- Oct 2006 (Actual)
- Completion
- Oct 2006 (Actual)
- Last update posted
- Sep 2, 2013
2005 – 2006
United States locations
- U.S. sites
- 19
- U.S. states
- 8
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Palo Verde Hematology Oncology Ltd. | Glendale | Arizona | 85304 | — |
| Comprehensive Blood & Cancer Center | Bakersfield | California | 93309 | — |
| Pacific Oncology & Hematology Associates | Encinitas | California | 92024 | — |
| Pacific Oncology and Hematology Associates | Encinitas | California | 92024 | — |
| Advanced Medical Research Institute | Fresno | California | 93710 | — |
| Kenmar Clinical Research | Los Angeles | California | 90057 | — |
| Kenmar Research Institute | Los Angeles | California | 90057 | — |
| Sant Chawla, Inc. | Santa Monica | California | 90403 | — |
| PAB Clinical Research | Brandon | Florida | 33511 | — |
| Melbourne Internal Medicine Associates | Melbourne | Florida | 32901 | — |
| Osler Medical, Inc./ Osler Clinical Research | Melbourne | Florida | 32901 | — |
| Bay Area Oncology | Tampa | Florida | 33607 | — |
| Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | — |
| Hematology Oncology Consultants, Inc. | Columbus | Ohio | 43235 | — |
| Charleston Cancer Center | Charleston | South Carolina | 29406 | — |
| South Carolina Oncology Associates | Columbia | South Carolina | 29210 | — |
| South Carolina Cancer Specialists | Hilton Head Island | South Carolina | 29926 | — |
| University of Texas Medical Texas | Galveston | Texas | 77555 | — |
| Multicare Health System | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00267358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 2, 2013 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00267358 live on ClinicalTrials.gov.